Account
Sign In
Home
Daily Diary
Asset Class
Fixed Income
Currencies
US Equity
Specialty
Global Equity & Income
Commodities
Sectors
Healthcare
Financial Services
Basic Materials
Consumer Cyclicals
Telecom Services
Energy
Transportation
Consumer Staples
Industrials
Utilities
Technology
Real Estate
Latest
Columnist Conversation
Video
Street Notes
Authors
Bruce Kamich
Jim Cramer
Jim "Rev Shark" DePorre
Brian Sozzi
Helene Meisler
Jonathan Heller
Roger Arnold
- See All -
Options
RMPIA
Switch Product
Action Alerts PLUS
Daily Swing Trade Archive
Income Seeker
Quant Ratings
Retirement
Stocks Under $10
TheStreet
Top Stocks
Trifecta Stocks
Information Provided By:
Visit TheFly.com
TheFly.com Free Trial
Fly News Breaks for August 15, 2019
TAK
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Takeda Pharmaceutical downgraded to Neutral from Outperform at Daiwa
Aug 15, 2019 | 05:49 EDT
Daiwa analyst Kazuaki Hashiguchi downgraded Takeda Pharmaceutical to Neutral from Outperform with a price target of 3,700 yen, down from 4,500 yen.
News For TAK From the Last 2 Days
TAK
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Takeda announces CHMP opinion recommending approval of fruquintinib
Apr 26, 2024 | 09:02 EDT
TAK
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Hutchmed announces positive CHMP opinion for fruquintinib
Apr 26, 2024 | 08:35 EDT